Drug developed for inherited bleeding disorder shows promising trial results
Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting one in 3,800 persons. HHT's hallmark symptom is chronic nosebleeds, which often occur alongside other ...
21 hours ago
0
19









